The apolipoprotein ε4 allele confers additional risk in children with familial hypercholesterolemia

Pediatric Research

Volumn 53, Issue 6, 2003, Pages 1008-1012

  Wiegman, Albert ^a,b   Sijbrands, Eric J G ^c   Rodenburg, Jessica ^b   Defesche, Joep C ^b   De Jongh, Saskia ^a   Bakker, Henk D ^a   Kastelein, John J P ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SIBLING;

EID: 0038278510     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000064580.23308.CB     Document Type: Article

References (47)

1. Goldstein JL, Hobbs HH, Brown MS 2001 Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th Ed. McGraw-Hill, New York, pp 2863-2913
2. Lansberg PJ, Tuzgöl S, Ree MA vd, Defesche JC, Kastelein JJP 2000 Higher prevalence of familiar hypercholesterolemia than expected in adult patients of four family practices in Netherlands [in Dutch]. Ned Tijdschr Geneeskd 144:1437-1441
3. Brown MS, Goldstein JL 1986 A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
4. Newman III WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS 1986 Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138-144
5. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group 1992 Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 152:56-64
6. Tonstad S, Leren TP, Sivertsen M, Ose L 1995 Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol 15:1009-1014
7. Davignon J, Gregg RE, Sing CF 1988 Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21
8. Zannis VI, Breslow JL 1981 Human very low density apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 20:1033-1041
9. Uterman G, Steinmetz A, Weber W 1982 Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. Hum Genet 60:344-351
10. Rall Jr SC, Mahley RW 1992 The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med 231:653-659
11. Uterman G, Pruin N, Steinmetz A 1979 Polymorphism of apolipoprotein E: effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 15:63-72
12. Wardell MR, Suckling PA, Janus ED 1982 Genetic variation in human apolipoprotein E. J Lipid Res 23:1174-1182
13. Bouthillier D, Sing CF, Davignon J 1983 Apolipoprotein E phenotyping with a single gel methods: application to the study of informative mating. J Lipid Res 24:1060-1069
14. Menzel H-J, Kladetzky R-G, Assman G 1983 Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 3:310-315
15. Robertson FW, Cumming AM 1985 Effects of apolipoprotein E polymorphism on serum lipoprotein concentration. Arteriosclerosis 5:283-292
16. Sing CF, Davignon J 1985 Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37:268-285
17. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Utermann G 1986 Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 27:227-235
18. Eto M, Watanabe K, Ishii K 1986 Reciprocal effects of apolipoprotein ε alleles (ε2 and ε4) on plasma lipid levels in normolipidemic subjects. Clin Genet 29:477-484
19. Boerwinkle E, Utermann G 1988 Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B and cholesterol metabolism. Am J Hum Genet 42:104-112
20. Kesäniemi YA, Ehnholm C, Miettinen TA 1987 Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80:578-581
21. Angelin B, Holmquist L, Leijd B, Einarsson K 1990 Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E2/2 phenotype. Eur J Clin Invest 20:143-149
22. Kesäniemi YA, Ehnholm C, Miettinen TA 1987 Within-population variation of serum cholesterol, apolipoprotein E phenotype and intestinal cholesterol absorption efficiency. Circulation 76(suppl IV):395
23. Demant T, Bedford D, Packard CJ, Shepherd J 1991 Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipidemic subjects. J Clin Invest 88:1490-1501
24. Tonstad S 1997 Familial hypercholesterolemia: how to identify children with FH. J Norwegian Soc Cardiol 10(suppl 3):32-37
25. National Cholesterol Education Program 1992 Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89(suppl):525-584
26. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL 1998 Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the third National Health and Nutrition Examination Survey. Prev Med 27:879-890
27. Smit M, Knijff P de, Rosseneu M, Bury J, Klasen E, Frants R, Havekes L 1988 Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levels. Hum Genet 80:287-292
28. Sugiuchi H, Uji Y, Okabe H, Irie T, Uekama K, Kayahara N, Miyauchi K 1995 Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated α-cyclodextrin. Clin Chem 41:717-723
29. Friedewald WT, Levy RJ, Frederickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18:499-502
30. Cheung MC, Albers JJ 1977 The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay. J Clin Invest 60:43-50
31. Albers JJ, Cabana VG, Hazzard WR 1975 Immunoassay of human plasma apolipoprotein B. Metabolism 24:1339-1351
32. Reymer PWA, Groenemeijer BE, Burg R v.d., Kastelein JJP 1995 Apolipoprotein E genotyping on agarose gels. Clin Chem 41:1046-1047
33. Yanagi H, Shimakura Y, Yamanouchi Y, Watanabe Y, Tsuchiya S, Hamaguchi H 1990 Association of hypercholesterolemia and apolipoprotein E4 in school children. Clin Genet 38:264-269
34. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G 1991 The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49:338-349
35. Xu CF, Talmud PJ, Angelico F, Ben MD, Savill J, Humphries SE 1991 Apolipoprotein E polymorphism and plasma lipid, lipoprotein and apolipoprotein levels in Italian children. Genet Epidemiol 8:389-398
36. Bercedo-Sanz A, Gonzalez-Lamuno D, Malaga S, Garcia-Fuentes M 1999 Impact of apo ε4 allele on total cholesterol levels of children in northern Spain. Clin Genet 55:69-70
37. Mahley RW, Huang Y 1999 Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol 10:207-217
38. Isasi CR, Shea S, Deckelbaum RJ, Couch SC, Starc TJ, Otvos JD, Berglund L 2000 Apolipoprotein ε2 allele is associated with an anti-atherogenic lipoprotein profile in children: the Columbia University BioMarkers Study. Pediatrics 106:568-575
39. Kallio MJT, Salmenperä L, Siimes MA, Perheentupa J, Gylling H, Miettinen TA 1997 Apolipoprotein E phenotype determines serum cholesterol in infants during both high-cholesterol breast feeding and low-cholesterol formula feeding. J Lipid Res 38:759-764
40. Kallio MJT, Salmenperä L, Siimes MA, Perheentupa J, Gylling H, Miettinen TA 1998 The apolipoprotein E phenotype has a strong influence on tracking of serum cholesterol and lipoprotein levels in children: a follow-up study from birth to the age of 11 years. Pediatr Res 43:381-385
41. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G 1999 Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: the Bogalusa Heart Study. Atherosclerosis 143:435-443
42. Defesche JC, Sauvage Nolting PWR de, Kastelein JJP 2000 Familial hypercholesterolemia: factors affecting phenotypic expression. In: Stenne S, Olson AG (eds) Atherosclerosis XII. Elsevier, Amsterdam, p 278
43. Berglund L, Wiklund O, Eggertsen G, Olofsson S-O, Eriksson M, Lindén T, Bondjers G, Angelin B 1993 Apolipoprotein E phenotypes in familial hypercholesterolemia: importance for expression of disease and response to therapy. J Intern Med 233:173-178
44. De Knijff P, Stalenhoef AF, Mol MJ, Gevers Leuven JA, Smit J, Erkelens DW, Schouten J, Frants RR, Havekes LM 1990 The influence of apoE polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 83:89-97
45. Sijbrands EJG, Lombardi MP, Westendorp RGJ, Gevers Leuven JA, Meinders AE, Van der Laarse A, Frants RR, Havekes LM, Smelt AHM 1998 Similar response to simvastatin in patients heterozygous for familial hypercholesterolemia with mRNA negative and mRNA positive mutations. Atherosclerosis 136:247-254
46. Ferrieres B, Lambert B, Lussier-Cacan S, Davignon D 1995 Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 92:290-295
47. Gerdes LU, Gerdes C, Kervinen K, Savolainen M, Klausen IC, Hansen PS, Kesämiemi YA, Færgeman O 2000 The apolipoprotein ε4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction Circulation 101:1366-1371